Correlation of tuberculosis-related anemia severity with tuberculosis-induced inflammation in children: a six-year

Chunjiao Han1,2, Yulian Fang1, Lili Dong3

  • 1Tianjin Children's Hospital, Children's Hospital of Tianjin University, Tianjin Pediatric Research Institute, Tianjin Key Laboratory of Birth Defects for Prevention and Treatment, Tianjin, China.

PubMed

Insights

Anemia affects over a third of children with tuberculosis (TB). This condition, often mild microcytic hypochromic anemia, correlates with inflammation severity and improves with treatment.

Area of Science:

  • Pediatric infectious diseases
  • Hematology
  • Tuberculosis research

Background:

  • Anemia is a frequent complication in tuberculosis (TB) patients.
  • Systematic studies on anemia in pediatric TB are lacking.
  • This study investigates anemia details in children with TB.

Purpose of the Study:

  • To describe anemia characteristics in children with TB.
  • To associate anemia with clinical features and inflammation.
  • To assess anemia as a TB severity biomarker in children.

Main Methods:

  • Retrospective analysis of 103 children with pulmonary TB (PTB).
  • Categorization into anemic and non-anemic groups based on hemoglobin (Hb) levels.
  • Logistic regression and Spearman correlation analyses for associations.

Main Results:

  • Anemia prevalence was 37.9% in pediatric TB patients.
  • Anemia linked to lower albumin and higher WBC, CRP, LDH, ESR.
  • Significant negative correlation between Hb and inflammatory markers.
  • 76.9% of children normalized Hb after one month of antitubercular therapy (ATT).

Conclusions:

  • Anemia is common in pediatric TB at diagnosis.
  • Mild to moderate microcytic hypochromic anemia predominates.
  • Anemia severity strongly correlates with TB-induced inflammation.
  • Anemia serves as a biomarker for TB severity in children.
Abstract

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
231
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
321
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
217
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177